Colorcon acquires division of Chr Hansen

Colorcon recently announced the acquisition of the pharma excipients and coating division of Chr Hansen. This acquisition expands Colorcon's global product offerings in the pharma and nutritional markets. Colorcon's core businesses include film coatings, modified release technologies, functional excipients and tablet design services pharma industry. In addition to coatings, acquired products include compressible sugars/NU-Tab(R), calcium carbonate/Cal-Carb(R) and sugar spheres. NU-Tab(R) is used in a wide range of chewable applications, including children's vitamins and medications, and for taste masking bitter or unpleasant drugs. Cal-Carb(R) is an ideal excipient for use in conventional tablets, as well as calcium and mineral supplement products. Sugar spheres are used primarily in controlled release formulations.

Controlled release formulations using multi particulates provide consistent drug release over time. Using sugar spheres, Colorcon expects to accelerate new product development efforts, as well as improve existing solutions for controlled release. The Stoughton, Wisconsin facility purchased from Chr Hansen will become an integral part of the Colorcon network of manufacturing sites. William Motzer, President and CEO, Color-con, states, "We're excited about this opportunity to expand Colorcon's product offerings and leverage our global distribution, technical service, and sales infrastructure."